Preclinical research: the bridge to new medicines
“Preclinical research serves as a bridge to new medicines,’’ says North-West University (NWU) academic Prof Rose Hayeshi, associate professor and director of the DSI/NWU Preclinical Drug Development Platform (PCDDP).
Preclinical drug development is one of the stages of development for new medicines and her specific interest is in drug metabolism.
Prof Hayeshi says the development of new medicines can be divided into two broad areas – discovery and development.